Clinical Trials Logo

IVF Treatment clinical trials

View clinical trials related to IVF Treatment.

Filter by:
  • None
  • Page 1

NCT ID: NCT03660813 Completed - IVF Treatment Clinical Trials

Follicle Size and Oocyte Development

AMJH
Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Studies have shown that the follicles greater in diameter was most likely to have a mature oocyte that was capable of fertilization and best suited for development into a high-quality embryo. Smaller follicles showed lower rates ( 60%). Lately new triggering protocols have emerged aiming to improve the proportion of mature oocytes at the time of retrieval. The aim of this study is to learn the effects of the dual triggering compared to the standard hCG triggering on the oocyte development and quality as a function of the follicle size

NCT ID: NCT01781143 Completed - IVF Treatment Clinical Trials

Self-operated Endo-vaginal Telemonitoring (SOET), an Economic and Patient-empowered Method for Ovarian Stimulation for In-vitro Fertilization (IVF)

SOET
Start date: January 2012
Phase: N/A
Study type: Interventional

The SOET project introduces a new strategy for routine follow-up of follicle growth during the hormonal treatment phase of an in-vitro fertilization (IVF) treatment cycle. After a learning instruction and demo, patients should be able to perform most of their vaginal echoes at home. The images can be sent to the medical center over the internet. These images are analyzed by the expert.

NCT ID: NCT01576744 Active, not recruiting - IVF Treatment Clinical Trials

Serum Biomarker HE4 During IVF Treatment

FHE4
Start date: March 2010
Phase: N/A
Study type: Observational

Human epididymal secretory protein 4 (HE4) is a new biomarker for ovarian cancer. The effect of IVF stimulation will be evaluated in order to see whether severe hormonal changes in the gonadotrophin and steroid status affect the serum levels of this marker. Findings will be compared to serum concentrations of CA-125, which is currently the most often used marker for ovarian cancer. The intention is to determine the serum concentration of HE4 and CA-125 in serial samples in 20 women undergoing IVF stimulation. Samples will be taken following GnRH agonist suppression, 2-3 times during FSH stimulation, at ovum pick up and two weeks following embryo transfer at the time of the hCG-test. The ovarian follicle count and the serum estradiol concentrations are recorded throughout the treatment. The serum biomarker HE4 is expected to ba a stable marker, which does not respond significantly to hormonal stimulation.

NCT ID: NCT00461422 Completed - Infertility Clinical Trials

Early Follicular Supplementation of Ganirelix in IVF 2004

Start date: January 2004
Phase: Phase 4
Study type: Interventional

Our goal was to investigate whether early follicular supplementation of the GnRH antagonist to the flexible GnRH antagonist protocol, has a potential to improve IVF-ET clinical results